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Abstract Protein phosphatase 5 (PP5) exhibits very low 
phosphatase activity, which can be stimulated > 25-fold by 
proteolysis. Since proteolysis cleaves the N-tenninal tetratrico-
peptide repeat (TPR) domain from the catalytic domain, these 
results indicate that the TPR domain shields the active site. 
Polyunsaturated fatty acids, such as arachidonic acid, and lipids 
containing polyunsaturated fatty acids, such as phosphatidylino-
sitol, stimulate both bacterially expressed human and native 
rabbit PP5 activity > 25-fold towards casein and myelin basic 
protein. Phosphatidylinositol binds to the TPR domain, and not 
to the catalytic domain, indicating that activation by polyun-
saturated fatty acids is allosteric and that it may occur by 
movement of the TPR domain to allow substrate access. 
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1. Introduction 
The dephosphorylation of serine and threonine residues is 
an essential process in the regulation of many cellular func-
tions. The major (PPP) family of serine/threonine phospha-
tases can be classified according to the structures of their 
catalytic subunits into four subfamilies, which are exemplified 
by PP1, PP2A, PP2B (calcineurin, Ca2+-calmodulin regulated 
protein phosphatase) and PP5 [1]. Unlike PP1, PP2A and 
PP2B, PP5 was identified from its cDNA rather than its cat-
alytic activity. Nevertheless PP5 is present throughout eukar-
yotes from man to yeast (where it is designated PPT), and in 
mammals PP5 is found in all tissues examined. It is predomi-
nantly located in the nucleus but is present at lower levels in 
the cytoplasm [2]. 
Although the function(s) of PP5 is (are) not known, identi-
fication of higher levels of PP5 in interphase cells in logarith-
mic growth than in dividing cells and serum deprived cells, 
together with increased levels of PP5 in the nucleolus subse-
quent to α-amanitin treatment of cells, suggests a role for PP5 
in the regulation of transcription [3]. The identification of PP5 
as a protein that interacts with the protein kinase domain of 
the guanylate cyclase receptor using the yeast two hybrid sys-
tem [4] suggests a role in cell signalling from this receptor to 
the nucleus. However, the presence of PP5 in cell types that 
do not possess the guanylate cyclase receptor and in nuclei 
indicates a wider role. PP5 is potently inhibited by the tumour 
promoters okadaic acid and microcystin with IC50 values in 
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the nanomolar range [2] and has recently been reported to be 
more sensitive than PP1, PP2A and PP2B to the fungal toxin 
fumonisin Bi with an IC50 value of 80 μΜ [5]. 
PP5 comprises a catalytic subunit which shows approxi-
mately 40% identity to PP1, PP2A and PP2B but, distinct 
from these enzymes, the catalytic domain of PP5 is preceded 
by a long N-terminal domain which contains four 34 amino 
acid repeats, termed tetratricopeptide repeats (TPR) [2,4,6]. 
Since these motifs are also found in many other proteins 
which participate in cell cycle events, RNA biosynthesis, pro-
tein import into mitochondria and peroxisomes and other 
processes, it is believed that TPR domains provide interfaces 
for protein-protein interactions (reviewed in [7]). Therefore 
the TPR domain of PP5 may target the phosphatase domain 
close to its substrate. 
Since human PP5 expressed in E. coli exhibited only low 
levels of phosphatase activity against a variety of conventional 
substrates [2], we sought to identify mechanisms that might 
trigger the activation of this enzyme. Here we report that both 
bacterially expressed human PP5 and native rabbit PP5 can be 
activated by proteolysis and by the binding of polyunsatu-
rated fatty acids to the TPR domain. The data indicate that 
the TPR domain shields the active site from entry by protein 
substrates and that lipids activate PP5 by movement of the 
TPR domain away from the active site. 
2. Materials and methods 
2.1. Materials 
All compounds were from Sigma unless otherwise stated. Arachi-
donic acid, arachidonic ethyl ester, arachidonyl acetate, linoleic acid, 
oleic acid, linolenic acid, sphingosine, were dissolved at concentrations 
of 10-60 mM in dimethylsulphoxide. Arachidic acid, stearic acid, 
nonadecanoic acid, cholesterol, phosphatidylcholine, phosphatidylser-
ine, phosphatidylethanolamine and diacylglycerol were dissolved in 
chloroform at 10-60 mM. Prostaglandin A2 was supplied in 10 mg/ 
ml methyl acetate solution. Phosphatidylinositol, phosphatidylinositol 
4-phosphate and phosphatidylinositol 4,5-bisphosphate, purified from 
Folch fractions (Sigma) and dissolved at 3-10 mM in chloroform, 
were gifts from P. Downes and S.J. James (University of Dundee). 
2.2. Bacterial expression and purification of PP5, its TPR and 
phosphatase domains 
Construction of plasmids expressing the virtually entire human PP5 
from R16 to M499 (HTW2), the TPR domain from R16 to L181 
(HTT1), and the catalytic domain from L181 to M499 (HTP1) in 
the pT7.7 vector and expression of these proteins in R. coli has 
been described previously [2] (Fig. 1). All proteins were insoluble 
when expressed at 37°C for 3 h. The insoluble proteins HTT1 and 
HTP1 were isolated from inclusion bodies, purified to homogeneity on 
SDS polyacrylamide gels as described previously [2], and used to raise 
antibodies in sheep. Anti-HTTl and anti-HTPl antibodies were affin-
ity purified, and detected 1 ng of HTT1 and HTP1, respectively, on an 
immunoblot. In cell extracts they detected a single PP5 band of 58 
kDa. Soluble forms of HTW2 and HTT1 were obtained by expression 
of the same constructs in R coli at a lower temperature (23°C) for 7 h. 
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Cells were lysed as described in [2]. Soluble HTW2 was purified to 
near homogeneity (Fig. 2) by 50-67% ammonium sulphate fractiona-
tion of the cell cytosol, followed by chromatography on S-Sepharose 
in buffer A (50 mM Tris-HCl pH 7.5, 0.1 mM EGTA, 0.03% Brij-35, 
0.1% 2-mercaptoethanol, 5% glycerol, 1 mM benzamidine and 0.1 
mM phenylmethylsulphonyl fluoride) plus 1 mM MnC^, with a 0-
500 mM NaCl gradient. HTW2 eluted at 310-340 mM NaCl. It was 
dialysed against buffer B (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 0.1 
mM EGTA, 0.03% Brij-35, 0.1% 2-mercaptoethanol, 50% glycerol) 
plus 1 mM MnCl2 at 4°C overnight, and stored at -20°C. HTT1 
was purified by a 17-33% ammonium sulphate fractionation, followed 
by chromatography on Mono Q in buffer A. HTT1 eluted at 190 mM 
NaCl. After heating to 95°C for 5 min and centrifugation at 
lOOOOXg, the supernatant, which contained homogeneous soluble 
HTT1 (Fig. 2), was dialysed against buffer B at 4°C overnight and 
stored at -20°C. 
2.3. Preparation of catalytically active phosphatase domain, HTP3 
180 μΐ of a 1 mg/ml trypsin solution was added to 2 mg of purified 
HTW2 in 20 ml in buffer A (without benzamidine and phenylmethyl-
sulphonyl fluoride). After incubation at 30°C for 10 min, 200 μΐ of 
5 mg/ml lima bean trypsin inhibitor was added to stop the reaction. 
The sample was applied to a Mono Q column in buffer A. A major 
casein phosphatase activity eluted at 180-200 mM NaCl. SDS poly-
acrylamide gel electrophoresis of this fraction revealed a protein of 39 
kDa, termed HTP3 (Fig. 2), which was dialysed against buffer B at 
4°C overnight and stored at —20°C. N-terminal sequence analysis of 
this protein was performed by Dr. Nick Morrice on an Applied Bio-
systems 476A sequencer. 
2.4. Purification of native PP5 from rabbit liver 
18 g rabbit liver was homogenised in 50 ml buffer C (50 mM Tris-
HCl pH 7.5, 100 mM NaCl, 0.1 mM EGTA, 0.1% 2-mercaptoethanol, 
1 mM benzamidine, 0.5 mM phenylmethylsulphonyl fluoride) and 
centrifuged at 15000Xg for 10 min at 4°C. PP5 was purified 10-
fold from the supernatant by a 45-60% ammonium sulphate fraction-
ation. The precipitated protein was dissolved in 60 ml buffer C, and 
PP5 was further purified 2.5-fold by a 10-15% polyethylene glycol 
6000 fractionation. The pellet was dissolved in 4 ml buffer A. 200 
μΐ of this sample was loaded onto a Mono Q column in buffer A, 
which was developed with a linear gradient of 0-500 mM NaCl. PP5 
eluted at 110-125 mM NaCl with a further 20-fold increase in purity. 
The overall purification of PP5 through these three steps was 500-fold. 
2.5. Protein phosphatase assays 
Cyclic AMP-dependent protein kinase (PKA, prepared by L.K. 
MacDougall) was used to phosphorylate partially hydrolysed bovine 
casein to 3.5 nmol phosphate per mg [8]. Myelin basic protein was 
phosphorylated by PKA to 1 mol phosphate/mol protein by H.A 
Snaith as described in [9]. The specific activity of the [γ-32Ρ]ΑΤΡ 
used for all phosphorylations was 106 cpm/nmol. Protein phosphatase 
assays were performed [10] in the absence of added divalent cations 
and most were in the presence of 0.33 mg/ml bovine serum albumin 
and 0.01% Brij-35. However, both albumin and detergent significantly 
lowered the sensitivity of PP5 to fatty acids. Therefore assays in the 
presence of fatty acids were conducted in the absence of these com-
ponents, which did not significantly affect the basal activity of the 
enzyme. The substrate concentrations in the assays were 6 μΜ for 
casein and 5 μΜ for myelin basic protein. Protein concentrations 
were determined by Coomassie Protein Assay reagent (Pierce, Rock-
ford, IL, USA). One unit of activity is the amount of enzyme which 
catalyses the release of 1 umol [32P]phosphate per min. 
2.6. Lipid vesicle binding to PP5 and its separate domains 
Large sucrose loaded unilamellar vesicles of phosphatidylinositol 
were prepared by extrusion through polycarbonate membranes, with 
pores of 100 run diameter, using a phospholipid extruder (Lipex Bio-
membranes) by X. Tang (University of Dundee) according to [11]. 30 
μΐ lipid vesicles were mixed with 30 ng protein in 30 ul buffer D 
comprising 10 mM HEPES pH 7.4, 3.4 mM EDTA, 150 mM NaCl, 
and incubated on ice for 10 min. Following centrifugation for 30 min 
at 4°C at 60000 rpm in a TLA100 rotor, 50 μΐ supernatant was 
recovered. The pellet was gently washed with ice-cold buffer D, and 
resuspended in 60 μΐ water. 7.5 μΐ samples of the supernatant and 
pellet fractions were denatured in SDS sample buffer, electrophoresed 
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on a SDS polyacrylamide gel, transferred to nitrocellulose membranes 
in order to determine the proportion of PP5 in each fraction. Immu-
noblotting was performed by incubation of the membranes with 1 μg/ 
ml affinity purified sheep anti-HTPl or anti-HTTl antibodies in 50 
mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% (w/v) Tween-20, 10% (w/ 
v) skimmed milk powder (Marvel) for 2 h at room temperature. Anti-
body binding was detected using 0.2 μ^ιηΐ horseradish peroxidase-
conjugated anti-sheep antibodies (Pierce), followed by Enhanced 
Chemiluminescence (Amersham International, UK). 
3. Results 
3.1. PP5 is activated by proteolytic cleavage of the TPR 
domain 
Human PP5 from amino acid R16 to the C-terminus 
(M499) was expressed as a soluble protein in E. coli, termed 
HTW2, with the leader sequence MARIAQ (Figs. 1 and 2), 
and purified to near homogeneity (Section 2.2). HTW2 had 
only very low phosphatase activity towards casein (14.7 mU/ 
mg) and myelin basic protein (1.2 mU/mg). The phosphatase 
activity was found to increase substantially after brief incuba-
tion of HTW2 with trypsin. This treatment released a proteo-
lytic fragment of approximately 39 kDa, termed HTP3, which 
was purified on Mono Q (Fig. 2) and shown to possess the 
phosphatase activity. The N-terminus of the HTP3 had the 
amino acid sequence S W D , which is found at position 160-
164 in PP5. Since S160 to the C-terminus of PP5 contains the 
entire catalytic domain and has a calculated molecular size of 
38.6 kDa, HTP3 is very likely to comprise amino acids S160-
M499. The specific activities of HTP3 towards casein (382 
mU/mg) and myelin basic protein (328 mU/mg) were 26-
and 260-fold higher respectively than those of HTW2. This 
suggests that the TPR domain may suppress the phosphatase 
activity of PP5. 
3.2. The activity of bacterially expressed and native PP5 is 
stimulated by fatty acids 
Various compounds were tested for their ability to stimulate 
the low phosphatase activity of HTW2. These included mole-
cules reported to influence protein phosphatase activity, such 
as protamine and spennine (reviewed in [12]), ceramide [9], 
and arachidonic acid [13]. The last mentioned was also re-
cently shown to activate a bovine brain phosphatase that 
had peptide sequences with similarities to those of human 
and rat PP5 [14]. Our results show that the polyunsaturated 
fatty acids, arachidonic acid, linoleic acid, oleic acid (Fig. 3), 
and linolenic acid stimulated the casein phosphatase activity 
of HTW2. The half-maximal activating concentrations (AC50) 
for these molecules were 125, 194, 213, and 270 μΜ respec-
tively. Arachidonic acid, the most effective activator, stimu-
lated activity 26-fold, similar to the increase in the casein 
phosphatase activity produced by proteolytic cleavage of the 
TPR domain from HTW2. Other compounds related to ara-
chidonic acid, including arachidonic ethyl ester and arachido-
nyl acetate, also stimulated PP5. In contrast, polysaturated 
lipids including arachidic acid, nonadecanoic acid and stearic 
acid failed to stimulate the enzyme. Structurally distinct lipids, 
including ceramide, sphingosine, cholesterol and prostaglan-
din A2, and other compounds including spennine, protamine, 
and histone HI also failed to cause stimulation. These results 
suggest a polyunsaturated fatty acid chain is essential for the 
stimulation of HTW2. The activity of HTW2 towards myelin 
basic protein was stimulated 57-fold by arachidonic acid. 
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The casein phosphatase activity of HTW2 was stimulated 
by several phospholipids, including phosphatidylinositol, 
phosphatidylinositol 4-phosphate, phosphatidylinositol 4,5-
bisphosphate, and phosphatidylserine. Eight- and seven-fold 
stimulation of HTW2 activity was observed in the presence of 
330 μΜ phosphatidylinositol and 220 μΜ phosphatidylinosi-
tol 4-phosphate, the highest concentrations which could be 
tested. These compounds appear to stimulate activity because 
they contain polyunsaturated fatty acid chains and an overall 
negative charge, since HTW2 was insensitive to the related 
compounds, phosphatidylcholine, phosphatidylethanolamine 
and diacylglycerol, which possess polyunsaturated fatty acid 
components, but are uncharged. However, since arachidonic 
ethyl ester and arachidonyl acetate stimulated HTW2, a net 
negative charge is not essential. 
We next investigated whether the casein phosphatase activ-
ity of native PP5 could also be stimulated by fatty acids. PP5 
was partially purified from rabbit liver (Section 2.4). Two 
peaks of casein phosphatase activity that were stimulated by 
arachidonic acid were detected in the final chromatography on 
Mono Q (Fig. 4A). The first peak, eluting at 110-125 mM 
NaCl, contained a 58 kDa protein that cross-reacted with 
anti-HTTl and anti-HTPl antibodies (Fig. 4B) and was there-
fore PP5. The basal phosphatase activity in this peak was 
inhibited by okadaic acid with IC50 value of approximately 
3 nM, similar to that measured for HTW2 [2]. Other proper-
ties of native PP5 were also very similar to the expressed 
enzyme. For example, the casein phosphatase activity was 
stimulated when the enzyme was briefly digested with trypsin 
(data not shown). The nature of the second peak of arachi-
donic acid stimulated phosphatase activity eluting from Mono 
Q (fractions 11-13) is not known. Although it was inhibited 
by 2 nM okadaic acid, it does not appear to be a closely 
related isoform of PP5 since it showed no cross reaction 
with anti-HTTl or anti-HTPl antibodies. 
3.3. The TPR domain of PP5 binds to lipids 
Unlike the full length PP5, the catalytic domain, HTP3, was 
PP5 Ml I VMMM,Ú ^ I M499 57 kDa 
HTW2 R16 I VMÍW/M"<á ^ ^ ^ ^ ^ ^ M ~ H M499 56 kDa 
HTTi we 1 mmm ι L M 2okDa 
HTP3 Slftl) i l Z Z ^ ^ ^ ^ ^ ^ ^ B Z j M499 39 kDa 
Fig. 1. Human protein phosphatase 5 (PP5) and fragments derived 
from it by expression in R. coli or by proteolysis of the expressed 
enzyme. The human PP5 sequence (amino acids E7-M499) is de-
scribed in GenEMBL data base accession number X89416 and [2]. 
Numbering of the amino acids is by comparison with the rat PP5 
[6] which is 98% identical to the human PP5 and has the sequence 
MAMAEG prior to E7. Bacterially expressed HTW2 is amino acids 
R16-M499 of human PP5 with the sequence MARIRA preceding 
R16. HTTI is the N-terminal TPR domain from R16-L181 with 
the same leader sequence and terminating with amino acids LGMM 
after L181. HTP1 is the phosphatase domain from L181-M499 with 
the leader sequence MARIRAQ. HTP3 is the catalytically active 
phosphatase domain starting at S160, which was produced by cleav-
age of HTW2 with trypsin. Hatched boxes denote the tetratricopep-
tide repeats and filled bars represent the phosphatase domain. 
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Fig. 2. Purified bacterially expressed human PP5, phosphatase and 
TPR domain fragments. Approximately 1 μg of each protein was 
electrophoresed in a 15% SDS polyacrylamide gel and stained with 
Coomassie Blue. Lane (M) contains molecular mass markers glyco-
gen phosphorylase (97 kDa), bovine serum albumin (66 kDa), oval-
bumin (43 kDa), carbonic anhydrase (29 kDa), soybean trypsin in-
hibitor (20 kDa), a-lactalbumin (14 kDa). Lanes (1) HTW2, (2) 
HTP3, and (3) HTTI. 
unaffected by arachidonic acid, linoleic acid or oleic acid (data 
not shown). This suggests that fatty acids may stimulate PP5 
by interacting with the TPR domain. Since fatty acids form 
micelles in solution, whereas phosphatidylinositol will form 
bilayer lipid vesicles, we used the latter to examine which 
region of PP5 bound to lipids. We tested whether HTW2, 
HTP3, and/or HTTI could bind to vesicles prepared from 
phosphatidylinositol [11,15] by incubation of these proteins 
with the hpid vesicles, followed by centrifugation to pellet 
the vesicles, and examination of supernatant and pellet frac-
tions by gel electrophoresis as described in Section 2.6. The 
experiments showed that both HTW2 and HTTI, but not 
HTP3, pelleted reproducibly with phosphatidylinositol vesicles 
(Fig. 5), demonstrating that the TPR domain is the region of 
PP5 that interacts with the fatty acid moiety of the lipid. 
4. Discussion 
4.1. The TPR domain prevents access of substrates to the active 
site of PP5 
Bacterially expressed (HTW2) and partially purified rabbit 
liver PP5 had very low phosphatase activity towards all sub-
strates tested, including phosphorylase [2], casein and myelin 
basic protein. Proteolytic cleavage of the TPR domain stimu-
lated both the expressed and native PP5 towards casein and 
myelin basic protein by 26- and 260-fold, respectively. It is 
therefore likely that the TPR domain acts as a shield to pre-
vent access of large substrates to the active site of the phos-
phatase domain, while permitting entry of small molecules. 
The very low basal phosphatase activity may indicate that 
the active site is not completely shielded, but a more likely 
explanation is that slight proteolytic cleavage gives rise to 
trace amounts of the fully active phosphatase domain in the 
HTW2 and PP5 preparations. 
4.2. Binding of polyunsaturated fatty acids to the TPR domain 
allosterically activates PP5 
Out of a wide range of substances tested, only polyunsatu-
rated fatty acids (arachidonic acid, linoleic acid, oleic acid) 
and their esters and negatively charged lipids containing ara-
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Fig. 3. Activation of bacterially expressed human PP5 (HTW2) by 
fatty acids. The abscissa is the concentration of the fatty acids and 
the ordinate is the fold stimulation by fatty acids of the basal casein 
phosphatase activity, which was measured in the absence of fatty 
acids. Open squares: arachidonic acid. Filled diamonds: linoleic 
acid. Filled squares: oleic acid. 
chidonic acid, such as phosphatidylinositol, activated bacte-
rially expressed and native PP5. The finding that the interac-
tion of phosphatidylinositol was with the TPR domain, and 
not the phosphatase domain, demonstrated that the fatty acid 
component does not directly influence the active site, but does 
so through binding to the TPR domain. Since arachidonic 
acid stimulated the casein phosphatase activity of the ex-
pressed PP5 by a similar magnitude to that observed on pro-
teolytic cleavage of the TPR domain (26-fold), fatty acid stim-
ulation and proteolytic activation may be occurring by similar 
mechanisms. Binding of fatty acid to the TPR domain may 
lead to exposure of the active site by movement of the TPR 
domain to such a degree as to allow access for protein sub-
strates. This is supported by the fact that inclusion of a 10-
fold molar excess of the TPR domain did not affect the casein 
phosphatase activity of HTW2 or the phosphatase domain, 
HTP3, in the presence or absence of arachidonic acid (data 
not shown), demonstrating that lipid-bound TPR domain is 
not directly stimulating the enzyme. The lower stimulation of 
HTW2 by arachidonic acid (57-fold) compared to proteolysis 
(260-fold) when myelin basic protein was the substrate may be 
due to the binding of the acidic lipids to the basic protein 
substrate. 
Although we have shown here that allosteric activation of 
native and expressed PP5 by lipids containing polyunsatu-
rated fatty acids occurs in vitro, it is not known whether 
the activation is of physiological significance. The AC50 for 
stimulation for any compound tested is > 100 μΜ, which is 
higher than would be expected for PP5 to be regulated by 
changes in lipid concentrations in vivo. However, it is possible 
that other molecules or particular subcellular locations may 
lower the AC50 and/or make the response specific to particular 
lipids. Arachidonic acid has been shown to inhibit the myosin 
light chain phosphatase activity of PP1 in smooth muscles, 
with an IC50 of 60 μΜ. The effect of arachidonic acid on 
PP1 might be somewhat analogous to its effect on PP5, in 
that it causes dissociation of the M-complex from the PP1 
catalytic subunit, which results in activation of the phosphor-
ylase phosphatase activity as well as inhibition of the myosin 
light chain phosphatase activity [13]. Arachidonic acid is also 
known to increase in response to signals that activate phos-
pholipase A2. 
TPR domains are thought to provide sites for protein-pro-
tein interactions. If PP5 contacts other protein(s) via the TPR 
domain and is also stimulated by lipids, a membrane location 
would be an ideal situation for PP5. In this respect it is inter-
esting that PP5 was found to interact with the guanylate cy-
clase receptor [4]. In addition we have obtained preliminary 
evidence that PP5 binds to proteins in a subcellular membrane 
fraction examined by gel electrophoresis (data not shown). 
Other protein domains are known which have been found 
to interact with lipids, for example some PH domains interact 
with phosphatidylinositol 4,5-bisphosphate [16]. The Ci do-
main found in protein kinase C and other proteins binds 
diacylglycerol and some forms of protein kinase C are also 
reported to be activated by arachidonic acid [17]. It will be 
interesting to know if hpid binding is a property of all or a 
subset of TPR domains. 
4.3. The TPR domain may be required for folding of the 
phosphatase domain 
Although HTW2 (R16-M499) and the proteolytic fragment 








IV.ii linn nmnliir S ·> Id 11 1: 11 14 
FPS—·► «.— 
» «■ III \\l 
Fig. 4. Arachidonic acid stimulation of native rabbit liver PP5 case-
in phosphatase activity. Partially purified PP5 was applied to a 
Mono Q column and a linear 0^ -500 mM NaCl gradient was used 
to elute 40 fractions which were assayed for casein phosphatase ac-
tivity in the presence and absence of 550 μΜ arachidonic acid. The 
ordinate shows the difference between casein phosphatase activity in 
the presence and absence of arachidonic acid and the abscissa the 
fraction number. Two peaks of arachidonic acid stimulated casein 
phosphatase activity are detected with maxima at fractions 9 and 
12. B: Immunoblot of fractions 8-14 with anti-HTPl antibodies. 
PP5 (57 kDa) was present in fractions 9 and 10. Lane C, HTW2 
control (56 kDa). 
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tone HI phosphatase activity although the specific activities 
were not reported. Since M107-M499 contains most of the 
third repeat and all of the fourth repeat in the TPR domain, it 
appears that this section of the TPR domain will suffice for 
sufficiently correct folding of PP5 to yield activity. 
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Fig. 5. The TPR domain of PP5 binds to phosphatidylinositol vesi-
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PP5), HTP3 (the phosphatase domain) and HTT1 (the TPR do-
main) were incubated with unilamellar vesicles of phosphatidylinosi-
tol. Lipid-bound and free protein were separated as described in 
Section 2. Samples were electrophoresed on a SDS polyacrylamide 
gel, transferred to nitrocellulose and probed with affinity purified 
anti-HTPl antibodies (lanes 1-6) and affinity purified anti-HTTl 
antibodies (lanes 7-9). Lanes 1, 2 and 3, HTW2; 4, 5 and 6, HTP3; 
7, 8 and 9: HTT1. Lanes 1, 4 and 7, total protein; 2, 5 and 8, 
60000Xg supernatant; 3, 6 and 9, 60000Xg pellet of phosphatidyl-
inositol vesicles. 
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